Skip to content
Research Article Open access CC BY 4.0

Clinical Symptoms and Haematological Characteristics among Male and Female COVID-19 Patients in Rivers State: A Single-center Case Reviews

Alali Dan- Jumbo, Tondor Cleopatra Uzosike, Mary Obidiya Okuku

Asian Journal of Research in Infectious Diseases · pp. 8–16 · Published 6 Jan 2021

10.9734/ajrid/2021/v6i130180

Abstract

Objectives: The study seeks to assess the sex differences in reported clinical symptoms and haematological parameters of hospitalized COVID-19 cases. Study Design: A retrospective descriptive cross-sectional study. Place and Duration of Study: Covid-19 Treatment Centre, Rivers State, between May 2020 and July 2020. Methodology: Descriptive data collection for patients diagnosed of COVID-19 was employed within the months of May to July 2020. A comparison of demographic profile, presenting symptoms, comorbidities and laboratory findings between males and females was analyzed using SPSS version 25. Ethical approval was obtained prior to commencing data collection. Results: In this study, data of 56 patients were analyzed of which 31 (55.4%) were males and 25 (44.6%) were females. The mean age for all patients was 36 years and males had a higher mean age (40 ± 12.6) compared to females (31 ± 8.8). Twelve patients (21.4%) reported pre-existing co-morbidities and Hypertension 11 (19.6%) was the prevalent co-morbidity followed by peptic ulcer 2 (3.6%) and Diabetes 2 (3.6%) and these were more common among males. Triglyceride level was significantly higher among females (p= 0.028) and low-density lipoprotein (LDL) level was significantly lower among females (p= 0.044) while systolic blood pressure level was significantly higher among males (p= 0.011). Conclusion: Though similar symptoms and haematological findings occur in males and females, specific disparities in some parameters were observed. We recommend healthcare personnel to consider these differences when caring for patients hospitalized for COVID-19.

COVID-19 sex symptoms haematological parameters.

References (24)

  1. 1 Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China [DOI]
  2. 2 Clinical Characteristics of Coronavirus Disease 2019 in China [DOI]
  3. 3 WHO Coronavirus Disease (COVID-19) Dashboard [DOI]
  4. 4 Epidemiology, causes, clinical manifestation and diagnosis, prevention and control of coronavirus disease (COVID-19) during the early outbreak period: a scoping review [DOI]
  5. 5 Comorbidity and its Impact on Patients with COVID-19 [DOI]
  6. 6 Real-time tracking of self-reported symptoms to predict potential COVID-19 [DOI]
  7. 7 Incubation Period and Other Epidemiological Characteristics of 2019 Novel Coronavirus Infections with Right Truncation: A Statistical Analysis of Publicly Available Case Data [DOI]
  8. 8 Transmission of COVID-19 virus by droplets and aerosols: A critical review on the unresolved dichotomy [DOI]
  9. 9 Clinical characteristics of coronavirus disease 2019 (COVID-19) in China: A systematic review and meta-analysis [DOI]
  10. 10 Laboratory abnormalities in patients with COVID-2019 infection [DOI]
  11. 11 Hematologic parameters in patients with COVID‐19 infection [DOI]
  12. 12 Potential preanalytical and analytical vulnerabilities in the laboratory diagnosis of coronavirus disease 2019 (COVID-19) [DOI]
  13. 13 Sex-specific clinical characteristics and prognosis of coronavirus disease-19 infection in Wuhan, China: A retrospective study of 168 severe patients [DOI]
  14. 14 A distinct name is needed for the new coronavirus [DOI]
  15. 15 Prevalence of Comorbidities in COVID-19 Patients: A Systematic Review and Meta-Analysis. [DOI]
  16. 16 Laboratory Findings of COVID-19 Infection are Conflicting in Different Age Groups and Pregnant Women: A Literature Review [DOI]
  17. 17 New loss of smell and taste: Uncommon symptoms in COVID-19 patients on Nord Franche-Comte cluster, France [DOI]
  18. 18 Clinical presentation, case management and outcomes for the first 32 COVID-19 patients in Nigeria [DOI]
  19. 19 Analysis of the primary presenting symptoms and hematological findings of COVID-19 patients in Bangladesh [DOI]
  20. 20 Anosmia: A marker of infection by the new corona virus [DOI]
  21. 21 Epidemiology of coronavirus disease 2019 (COVD-19) outbreak cases in Oyo State South West Nigeria, March-April 2020 [DOI]
  22. 22 Attitudinal, regional and sex related vulnerabilities to COVID-19: Considerations for early flattening of curve in Nigeria. [DOI]
  23. 23 Sex differences in clinical findings among patients with coronavirus disease 2019 (COVID-19) and severe condition [DOI]
  24. 24 Sex Differences in Clinical Characteristics and Risk Factors for Disease Severity of Hospitalized Patients with COVID-19 in Beijing [DOI]

Cited by 0

No indexed citations yet.

Related research

Article metrics

Real usage data collected on this platform.

61

Page views

0

PDF downloads

29

Outbound clicks

0

Citations

Views over time

Views by country

Approximate, from request IP at view time — not citizenship or institution. Countries with fewer than 5 views are grouped as "Other".

Traffic sources

Referring site, by host.

Views and downloads exclude known bots/crawlers. Citations combines this platform's own DOI-resolved index with each external source's own reported total — see Cited by above for individually listed citing works. Last refreshed 0 seconds ago.